from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3543c/fadE29

LFCtreatmentdescriptionclass of inhibitor

-0.400

Amikacinug/mL Amikacintranslation

-0.542

Cap5-10ug/mL Capreomycintranslation

-0.315

Rox10-50 ug/mL Roxithromycintranslation

-0.015

SM2-5 ug/mL Streptomycintranslation

-1.491

Tet5-10 ug/mL Tetracyclinetranslation

-0.245

Rif0.2-5ug/mL Rifampicintranscription

-0.237

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.488

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.025

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.181

CPZ10-50 ug/mL Chlorpromazinerespiration

0.027

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.025

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.910

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.710

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.309

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.234

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.058

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.070

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.555

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.388

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.066

KCN5-20 ug/mL Potassium cyaniderespiration

-0.506

NaN30.2-2 mM Sodium aziderespiration

-0.020

Nigericin50 uM Nigericinrespiration

0.736

TRC10-150 ug/mL Triclosanrespiration

0.105

TRZ10-25 ug/mL Thioridazinerespiration

0.354

Valinomycin0.5-10 uM Valinomycinrespiration

0.620

ZnSO42 mM ZnSO4respiration

0.071

menadione6-10 ug/mL Menadionerespiration

3.318

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.175

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.116

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.373

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.603

NRP_1Non-replicating persistence stage 1dosRassociated

-0.035

Amp0.2mg/mL AmpicillincellWall

-0.116

Cephalexin20-100 ug/mL CephalexincellWall

-0.193

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.453

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.325

EMB10-20 ug/mL EthambutolcellWall

-0.133

Eta12-40 ug/mL EthionamidecellWall

-0.267

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.172

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.686

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.933

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.451

BZA0.12 mg/mL BenzamidearomaticAmides

-0.568

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.298

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.439

H2O24 mM hydrogen peroxideDNAdamaging

0.299

Levo10 ug/mL LevofloxacinDNAdamaging

-0.848

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.206

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.185

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.308

UVUV-irradiationDNAdamaging

-0.123

ARP41-4 ug/mL Antitubercular compound ARP4?

0.122

Antimycin12.5-50 ug/mL Antimycin A?

0.065

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.287

PA_110-50 ug/mL Antitubercular compound PA-1?

0.320

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.063

PA8240.2-2 ug/mL PA-824?

2.363

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.483

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.557

Verapamil50 uM Verapamil?

0.182

mercaptoethanol2 mM 2-Mercaptoethanol?

0.967

methoxatin10-20 ug/mL Methoxatin?